Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

California partners with Civica Rx for affordable insulin

The state of California and Civica Rx have penned a 10-year deal to deliver insulin at a reduced rate. The medicines will be available in vials and prefilled pens under the CalRx label. 

Thumbnail

Healthcare disparities, uninsured rate both improving

In the last few years, uninsured rates dropped to a historic low of 8%, while racial disparities across healthcare have also vastly improved, according to a new report from the Commonwealth Fund.

Healthcare fraud running rampant in South Florida

South Florida is “ground zero” for healthcare fraud, with companies popping up left and right ready to bilk Medicare and Medicaid for millions of dollars.

Pfizer recalls 4 million units of migraine medicine

The recalled products are not child resistant, posing a poison risk if the contents are swallowed by young children.

Medicare money payment physician

These 27 drugs will be subject to Medicare rebates

The Medicare Prescription Drug Inflation Rebate Program will lower coinsurance for Medicare Part B beneficiaries for certain drugs, with savings between $2 and $390 per average dose starting April 1.

Thumbnail

Physicians sound off on prior authorization burdens on patients

Recent survey findings underscore that the vast majority of physicians believe prior authorization has a negative impact on patient care. In fact, some specialists think it leads to worse outcomes.

 

venture capital corporate suit business corporatization

Medtronic, Edwards among the healthcare organizations chosen as World’s Most Ethical Companies in 2023

The annual list, now in its 17th year, was designed to celebrate companies that make ethical business practices a high priority. 

Thumbnail

New guidance details Medicare drug price negotiations coming in 2026

For the first time, Medicare will have the ability to negotiate prices of certain medications. These negotiations will focus on key questions such as the drug's benefits, the extent to which it fulfills an unmet medical need and its impact on Medicare beneficiaries.

Around the web

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

These companies were already part of the Johnson & Johnson family, but they had still retained their previous brand names. Now, each one is officially going by Johnson & Johnson MedTech. 

Trimed Popup
Trimed Popup